Literature DB >> 34478118

Hypertension and Hypercholesterolemia are Associated with Cataract Development in Patients with Type 2 Diabetes.

Martina Tomić1, Romano Vrabec1, Petar Raštegorac2, Spomenka Ljubić3,4, Tomislav Bulum5,6, Dario Rahelić3,4.   

Abstract

INTRODUCTION: Patients with diabetes have up to five times higher incidence of cataract, mainly at a younger age, and cataract in these patients progresses more rapidly than senile cataract, especially in eyes affected with sight-threatening diabetic retinopathy (DR). AIM: This study aimed to investigate the risk factors associated with cataract development in patients with type 2 diabetes (T2DM).
METHODS: This case-control cross-sectional study included 90 T2DM (56M/34F). Metabolic risk factors glycated hemoglobin (HbA1c), total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides were determined using routine laboratory methods. Blood pressure was measured with a mercury sphygmomanometer after a 10-min resting period. Lens opacity was graded according to the Lens Opacity Classification System version III (LOCS III).
RESULTS: According to the LOCS III, patients were divided into two groups: group 1-patients with clear crystalline lens, and group 2-patients with initial cataract. Compared to patients with a clear crystalline lens, those with initial cataract had longer diabetes duration (p = 0.002), higher HbA1c (p = 0.037), higher total cholesterol (p = 0.029), higher diastolic blood pressure (DBP) (p = 0.014), and lower creatinine clearance (p = 0.017). Cataract was positively associated with diabetes duration (p = 0.001), HbA1c (p = 0.035), LDL cholesterol (p = 0.042), and DBP (p = 0.009), while negatively with creatinine clearance (p = 0.005). Logistic regression analysis showed that the influence of DBP (AOR = 1.06, p = 0.014) and creatinine clearance (AOR = 2.93, p = 0.045) on cataract development remained significant even after adjustment for diabetes duration and HbA1c.
CONCLUSIONS: Diabetes duration and various metabolic risk factors, particularly poor glycemic control, hypercholesterolemia, DBP, and diabetic nephropathy's coexistence, are associated with cataract development in T2DM.
© 2021. Italian Society of Hypertension.

Entities:  

Keywords:  Cataract; Hypercholesterolemia; Hypertension; Type 2 diabetes

Mesh:

Year:  2021        PMID: 34478118     DOI: 10.1007/s40292-021-00472-8

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  29 in total

1.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors:  A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17.

Authors:  Rajiv Raman; Swakshyar Saumya Pal; James Subrat Kumar Adams; Padmaja Kumari Rani; Kulothungan Vaitheeswaran; Tarun Sharma
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-07       Impact factor: 4.799

3.  Metabolic syndrome components and age-related cataract: the Singapore Malay eye study.

Authors:  Charumathi Sabanayagam; Jie Jin Wang; Paul Mitchell; Ava Grace Tan; E Shyong Tai; Tin Aung; Seang-Mei Saw; Tien Yin Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-14       Impact factor: 4.799

Review 4.  Serious adverse events after cataract surgery.

Authors:  Joshua D Stein
Journal:  Curr Opin Ophthalmol       Date:  2012-05       Impact factor: 3.761

5.  The association between diabetes and cataract among 42,469 community-dwelling adults in six low- and middle-income countries.

Authors:  Damiano Pizzol; Nicola Veronese; Gianluca Quaglio; Francesco Di Gennaro; Davide Deganello; Brendon Stubbs; Ai Koyanagi
Journal:  Diabetes Res Clin Pract       Date:  2018-12-06       Impact factor: 5.602

6.  Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; H Andrew W Neil; David R Matthews
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

Review 7.  Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.

Authors:  Seth R Flaxman; Rupert R A Bourne; Serge Resnikoff; Peter Ackland; Tasanee Braithwaite; Maria V Cicinelli; Aditi Das; Jost B Jonas; Jill Keeffe; John H Kempen; Janet Leasher; Hans Limburg; Kovin Naidoo; Konrad Pesudovs; Alex Silvester; Gretchen A Stevens; Nina Tahhan; Tien Y Wong; Hugh R Taylor
Journal:  Lancet Glob Health       Date:  2017-10-11       Impact factor: 26.763

8.  Hypertension and risk of cataract: a meta-analysis.

Authors:  Xiaoning Yu; Danni Lyu; Xinran Dong; Jiliang He; Ke Yao
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

Review 9.  Cataract in diabetes mellitus.

Authors:  Hasan Kiziltoprak; Kemal Tekin; Merve Inanc; Yasin Sakir Goker
Journal:  World J Diabetes       Date:  2019-03-15

10.  Discovery of High Affinity Receptors for Dityrosine through Inverse Virtual Screening and Docking and Molecular Dynamics.

Authors:  Fangfang Wang; Wei Yang; Xiaojun Hu
Journal:  Int J Mol Sci       Date:  2018-12-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.